Essex Savings Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-454
Closed -$236K 300
2024
Q3
$236K Hold
454
0.06% 256
2024
Q2
$246K Hold
454
0.07% 226
2024
Q1
$214K Hold
454
0.06% 244
2023
Q4
$214K Buy
+454
New +$210K 0.06% 244
2023
Q2
Sell
-494
Closed -$227K 230
2023
Q1
$227K Sell
494
-190
-28% -$90.4K 0.08% 202
2022
Q4
$351K Buy
684
+95
+16% +$48.2K 0.12% 155
2022
Q3
$268K Hold
589
0.11% 166
2022
Q2
$284K Sell
589
-63
-10% -$31.2K 0.11% 164
2022
Q1
$320K Buy
652
+188
+41% +$85.9K 0.11% 163
2021
Q4
$215K Buy
+464
New +$195K 0.07% 209
2019
Q3
Sell
-606
Closed -$171K 306
2019
Q2
$171K Buy
606
+406
+203% +$111K 0.06% 250
2019
Q1
$57K Hold
200
0.03% 275
2018
Q4
$53K Buy
+200
New +$55K 0.03% 285

Other funds holding ELV

Essex Savings Bank's ELV Position: Q4 2024 in Review

Essex Savings Bank sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 454 shares — an estimated $236K sold.

Essex Savings Bank first reported a position in ELV in Q4 2018 and held it in 13 quarters. The position peaked at $351K in Q4 2022. 1,603 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Essex Savings Bank reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Essex Savings Bank sold 454 Elevance Health shares in Q4 2024, an estimated $236K.
  • Essex Savings Bank first reported a position in Elevance Health in Q4 2018 and held it in 13 quarters.
  • Essex Savings Bank's Elevance Health position peaked at $351K in Q4 2022.
  • 1,603 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Essex Savings Bank's 13F filing for Q4 2024, filed 14 Jan 2025.